School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination by Davies, C. et al.
Vaccine 39 (2021) 4190–4198Contents lists available at ScienceDirect
Vaccine
journal homepage: www.elsevier .com/locate /vacc ineSchool-based HPV vaccination positively impacts parents’ attitudes
toward adolescent vaccinationAbbreviations: HPV, Human papillomavirus; NIP, National Immunisation Program; SBV, School-based vaccination; DST, Decisional Support Tool.
⇑ Corresponding author at: Specialty of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Locked Bag 4001, Westmead, NS
Australia.
E-mail: Cristyn.Davies@sydney.edu.au (C. Davies)
1 The HPV.edu study group We would like to acknowledge the contributions to this study by members of the HPV.edu Study Group, including: Professor Annette B
Mayer: Australian Centre for Health Engagement, Evidence and Values, School of Health and Society, Faculty of Arts, Social Sciences and Humanities, University of Wo
NSW, Australia; Dr. Joanne Collins: Women’s and Children’s Health Network and School of Medicine and Robinson Research Institute, University of Adelaide, SA, A
Associate Professor Spring Cooper: School of Public Health, City University of New York, New York, NY, USA; Professor Suzanne M. Garland: Centre Women’s Infectious
Research, The Royal Women’s Hospital, Melbourne, Vic., and Reproductive and Neonatal Infectious Diseases, Department of Obstetrics and Gynaecology, University of Me
Murdoch Children’s Research Institute, Vic., Australia; Jane Jones: Telethon Kids Institute, University of Western Australia, WA, Australia; Professor John Kaldor: T
Institute for Infection and Immunity in Society, Faculty of Medicine, UNSW Sydney, NSW, Australia; Associate Professor Kevin McGeechan, School of Public Health, F
Medicine and Health, University of Sydney, NSW, Australia; Associate Professor David G. Regan: The Kirby Institute for Infection and Immunity in Society, Faculty of M
UNSW Sydney, NSW, Australia; Professor Peter Richmond: Vaccine Trials Group, Vaccine Trials Group, Wesfarmers Centre of Vaccines and Infectious Diseases, Telet
Institute, Perth, WA, Australia, and School of Paediatrics and Child Health, University of Western Australia, Perth, WA, Australia; Patti Whyte, Deakin University, SRC Po
Health, Deakin Health Economics, Melbourne, Vic., Australia.
https://doi.org/10.1016/j.vaccine.2021.05.051
0264-410X/ 2021 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Cristyn Davies a,⇑, Tanya Stoney b, Heidi Hutton b, Adriana Parrella c,d, Melissa Kang e,
Kristine Macartney a,f, Julie Leask g, Kirsten McCaffery h, Gregory Zimet i, Julia M.L. Brotherton j,
Helen S. Marshall c, S. Rachel Skinner a, for the HPV.edu study Group1
a Speciality of Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, NSW, Australia
b Telethon Kids Institute, University of Western Australia, WA, Australia
cWomen’s and Children’s Health Network and School of Medicine and Robinson Research Institute, University of Adelaide, SA, Australia
d South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia
e School of Public Health, Faculty of Health, University of Technology Sydney, NSW, Australia
fNational Centre for Immunisation Research and Surveillance, Sydney, Australia
g Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, NSW, Australia
h Sydney School of Public Health, Faculty of Medicine and Health, Sydney Health Literacy Lab, University of Sydney, NSW, Australia
iDepartment of Pediatrics, Indiana University, Indianapolis, IN, USA
jVCS Population Health, VCS Foundation, and Melbourne School of Population and Global Health, University of Melbourne, Vic., Australia
a r t i c l e i n f oArticle history:
Received 17 July 2020
Received in revised form 13 May 2021
Accepted 19 May 2021










Implementationa b s t r a c t
Introduction: This qualitative study aimed to explore parental attitudes, knowledge and decision-making
about HPV vaccination for adolescents in the context of a gender-neutral school-based Australian
National Immunisation Program (NIP).
Methods: Semi-structured interviews with parents of adolescents eligible for HPV vaccination were
undertaken as part of an evaluation of a cluster-randomised controlled trial of a complex intervention
in 40 schools (2013–2015). In this qualitative study, we purposively recruited a nested sample of parents
from 11 schools across two Australian jurisdictions. Interviews explored parent knowledge and under-
standing of the HPV vaccine program; HPV vaccination decision-making; their adolescent’s knowledge
about HPV vaccination; and their adolescent’s understanding about HPV vaccination, sexual awareness
and behaviour. Transcripts were analysed using inductive and deductive thematic analysis.
Results: Parents’ of 22 adolescents had positive attitudes towards the program; the school-based delivery
platform was the key driver shaping acceptance of and decision-making about HPV vaccination. They had
difficulty recalling, or did not read, HPV vaccination information sent home. Some adolescents were
involved in discussions about vaccination, with parents’ responsible for ultimate vaccine decision-
making. All parents supported in-school education for adolescents about HPV and HPV vaccination.
Parents’ knowledge about HPV vaccination was limited to cervical cancer and was largely absent regard-
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C. Davies, T. Stoney, H. Hutton et al. Vaccine 39 (2021) 4190–4198Conclusions: Parents’ positive attitudes towards the NIP and inclusion of the HPV vaccine is central to
their vaccine decision-making and acceptance. More intensive communication strategies including
school education opportunities are required to improve parents’ knowledge of HPV-related disease and
to promote vaccine decision-making with adolescents.
 2021 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Globally, there is suboptimal uptake of HPV vaccines for eligible
adolescents [1]. In countries with gender-neutral HPV vaccination,
there are also disparities in uptake by sex of the adolescent, as indi-
cated by lower vaccine coverage for males [1,2]. In Australia, three-
dose quadrivalent HPV (4vHPV) vaccine coverage for females
(vaccination program commenced from 2007) was 80.2% and for
males (vaccination program commenced from 2013) was 75.9%
for adolescents turning 15 years in 2017 [3].2 The two-dose nonava-
lent HPV (9vHPV) vaccine coverage for adolescents turning 15 years
in 2019, was 82.6% in females and 79.9% in males [4].3 Currently
gender-neutral HPV vaccination programs are not universal, given
the high costs of the vaccine and global limitations in vaccine supply.
In addition, the World Health Organization recommends prioritizing
vaccination for females [5]. Given that genital HPV is the most preva-
lent sexually transmitted infection, with approximately 90% of the
population estimated to be infected in their lifetime [6], prophylactic
HPV vaccination is most effective if administered to adolescents
before sexual debut [7]. Parents and guardians (hereafter referred
to as ‘parents’) play a pivotal role in ensuring vaccine uptake, given
that in many countries including Australia, parental consent is
required for adolescent vaccination in schools [8]. Parents’ knowl-
edge, attitudes and beliefs about vaccines in general, and HPV and
HPV vaccination in particular, can influence their decision-making
about HPV vaccination for their adolescent [1,9–11]. Key factors
influencing parental HPV decision-making include: physician
recommendation, government recommendation, parents’ perceived
benefits of the vaccine for their adolescent, parents’ concerns about
vaccine safety and for some, worries about sexual risk compensation
[1,11–13].
School-based vaccination (SBV) is considered the most effective
and efficient means of ensuring high vaccine coverage for adoles-
cents [14–17], especially given the decline in frequency of visits
to primary care practitioners in adolescence compared with child-
hood [18]. In Australia, the school-based immunisation program
has strong parental and community support for delivery of adoles-
cent immunisations due to convenience, no cost to families, ease of
access, and adolescent peer support on vaccination day [15,19].
Unlike the administration of childhood vaccines, there is generally
no direct contact between healthcare providers and parents of ado-
lescent vaccine recipients at the time of consent. Schools distribute
parental consent forms and information to students to take home
for signing [20]. This limits opportunities for verbal communica-
tion regarding vaccine decision-making and provision of informa-
tion about HPV and its impact on health, also termed HPV
vaccine health literacy [21].
Understanding parental attitudes and knowledge about HPV
and HPV vaccination for adolescents and their perspectives
about logistical barriers in the context of establishedgister before data collection
on 9/30/2016.
y 2020. As documented in the
mavirus vaccination program
om AIR (based on age at 31
l data trends from previous
7).
4 Six intervention and six control groups were recruited from the main study
however in one control school, only observations were conducted not paren4191school-based programs may provide insights into HPV vaccine
decision-making and aid in refining vaccine delivery implemen-
tation strategies to increase uptake. Here we aimed to explore
parental attitudes, knowledge and decision-making about HPV
vaccination for adolescents in the context of school-based
program delivery.
2. Methods
As part of the process evaluation of a cluster-randomised con-
trolled trial of a complex education and logistical intervention in
40 schools in two Australian jurisdictions (2013–2015), we under-
took semi-structured interviews with parents of adolescents
eligible for HPV vaccination. This study was undertaken when a
three-dose quadrivalent HPV vaccine schedule was in place. The
main study (HPV.edu) [20] aimed to examine: 1) student knowl-
edge about HPV vaccination [22]; 2) psycho-social outcomes [23]
and 3) vaccination uptake. Intervention schools received an adoles-
cent intervention (education and distraction on the day) [24], a
shared decisional support tool (DST) for parents and adolescents,
and logistical strategies detailed below. The intervention resulted
in large gains in student knowledge in intervention compared to
control schools [22].
2.1. Study Intervention
The intervention was designed to promote adolescent knowl-
edge, decision-making involvement and confidence in vaccination,
and to reduce vaccination-related anxiety. Logistical strategies
were designed to improve vaccination uptake, school vaccination
processes and adolescent experience. A DST was sent home with
vaccine eligible adolescents at the same time as the vaccination
consent form [20]. The development of our intervention was
informed by a broad biopsychosocial model including the Health
Belief Model, the Theory of Planned Behaviour and Social Cognitive
Theory as described in Cooper et. al [24]. These theories allowed for
the identification of beliefs about vaccination, underlying health
status and previous experiences with vaccine-preventable diseases
during resource co-design, development and evaluation phases. In
this paper, we employed an ecological framework to understand
the psychological, social and organisational levels of influence on
parents within an adolescent school vaccination system [25]. Par-
ents were invited to participate in interviews, and we present
the findings here.
2.2. Participants and recruitment
The study was conducted in Western Australia (WA) and
South Australia (SA) with parents of vaccine eligible adolescents
from the nested sample of 11 (5 control; 6 intervention) schools
participating in the process evaluation of the main study (HPV.
edu).4 These case study schools were purposively recruited,
stratified by government, Catholic, and independent sectors andinterviews due to the school’s resource limitations.,
t
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recruitment materials to use at their discretion, and as per their
usual communication mechanisms, to invite parental participation
in interviews. Purposeful sampling was used to recruit parents of
vaccine eligible adolescents who were available and willing to par-
ticipate in the study. Study promotional materials and interviews
were in English language only. Research team members scheduled
face-to-face interviews with parents at a mutually convenient time
and location.2.3. Data collection
Members of the research team in each jurisdiction conducted
interviews. Interviewers invited parents to respond to questions
about their knowledge and understanding of the school-based
HPV vaccine program; HPV vaccination decision-making; their
adolescent’s knowledge about HPV and HPV vaccination; and
their adolescent’s understanding about HPV vaccination, sexual
awareness and behaviour (please see appendix). Parent inter-
views took place after the time period in which HPV dose two
or three had been offered in the school program. To ensure a con-
sistent approach, the first author also participated in some
research interviews with parents across jurisdictions. Interviews
were digitally recorded, transcribed verbatim, and field notes
were taken by researchers involved in the interview. Data collec-
tion stopped once data saturation (or data adequacy) was
achieved [26,27].2.4. Data analysis
Participant transcripts were coded in NVivo9. Thematic analysis
is a method for identifying, analysing and reporting recurring
themes developed from the data [28]. Inductive and deductive
approaches were used to generate codes employed across the data
set. The first author developed codes with input from the research
team and from two research student assistants. The first author
participated in and supervised two research students who shared
the task of coding the data sentence by sentence across the data
set, developing and discussing themes. Conceptual saturation
was reached when no new codes were able to be generated [26].
The first author performed an overall analysis to ensure that
diverse themes identified from the data set were represented. The-
matic analysis was undertaken within the context of an ecological
theoretical framework considering different levels of influence
[25].2.5. Ethics and informed consent
We obtained ethical approval from all relevant bodies across
research sites. This included the Department of Health WA Human
Research Ethics Committee (HREC), Women’s and Children’s
Hospital HREC, and relevant government authorities. Approval
for analysis of data was also granted by the University of Sydney,
Australia. Parents provided consent for their participation and
were invited to review their own transcript at the time of
interview.5 Two participants parented the same adolescent; thus, parent observations are
ade regarding 21 adolescents.2.6. Advisory Board
Our study Advisory Board had representatives from the health
department and immunisation teams in both study jurisdictions,
and the government, Catholic and independent education
sectors. The advisory board provided input on all aspects of
the study.41923. Results
3.1. Parent demographics
Twenty-two parents participated in interviews across school
sectors (19 mothers, 3 fathers). Participants were parents of 21
adolescents (14 females, 7 males) from 14 control and 8 interven-
tion schools.5 Nineteen parents reported that their adolescent
received at least one dose of the three-dose HPV vaccine regime
(eight received three HPV vaccine doses, six received two doses,
three received one dose), two parents did not know their adoles-
cent’s HPV vaccine status, two parents reported that their adolescent
had not received the HPV vaccine, and one parent did not provide a
response. All doses of HPV vaccine were administered at school
except one adolescent who had all doses with a primary care practi-
tioner. Most parents spoke English as their main language at home
(n = 19). Seven parents had high school qualifications, four parents
had apprenticeship/TAFE qualifications, ten parents had university
qualifications, and one parent did not report her education Table 1.
3.2. Key findings
We developed three core themes from this data set: A) Parents’
positive attitudes towards the HPV vaccine and the NIP in general
(hereafter called ‘‘the Program”), B) HPV vaccine inclusion in the
Program is central to parents’ vaccine decision-making and accep-
tance, C) Parents’ knowledge about HPV and HPV vaccination is
limited, especially regarding males. Quotes from parents high-
lighted below and in tables two to four are illustrative of percep-
tions, attitudes and experiences of participants in this study.
A. Parents’ positive attitudes towards the HPV vaccine and the NIP
in general
Parents trusted clinicians, researchers and government regard-
ing vaccine safety and inclusion of well-researched vaccines in
the Program, with one parent reporting: ‘I know that it would have
gone through clinical trials’ (PWA015, Intervention). They highlighted
the importance of adolescent peer support on vaccination day
within the school-setting:
She has got that support of her friends rather than [. . .] getting
dragged to the doctor with your mum. (PWA017, Intervention)
Parents reported that they may be more likely to defer or miss
immunisations if they were only administered in traditional clini-
cal settings due to inconvenience. One parent commented, ‘most
parents work, to take time off at the end of the day it means the par-
ents will lose dollars, they will forget, they will put it off’ (PWA005,
Control). They commented on the importance of government sub-
sidisation of vaccines, which made the HPV vaccine more accessi-
ble to all adolescents. Parents expressed a strong desire to track
their adolescent’s vaccine record, and some observed that vaccina-
tion consent forms, if couriered by the adolescent, may or may not
reach the parent, or designated school vaccination coordinator
Table 2.
B. HPV vaccine inclusion in the Program is central to parents’ vac-
cine decision-making and acceptance
The inclusion of the HPV vaccine in the Program is central to
parental vaccine decision-making and acceptance, acting as a sig-
nal of societal endorsement:
I don’t need to consciously make that decision. Vaccination
programs have been demonstrated over history to be absolutely
beneficial. There is no reason that I wouldn’t vaccinate her against
























PWA001 Control F F Catholic Yes 3 New Zealand Yes Postgraduate
PWA002 Control F F Catholic Yes 2 Australia Yes High School
PWA003 Control M M Catholic Yes 3 New Zealand Yes High School
PWA004 Control F F Government Yes 2 Australia Yes High School
PWA005 Control F M Catholic Yes 1 Australia 2 Yes Postgraduate
PWA006 Control F F Catholic Yes 1 Australia Yes High School
PWA007 Control F F Government Yes 2 UK Yes Postgraduate
PWA008 Control F M Government No 0 USA Yes Undergraduate
PWA0093 Control F F Government Yes 3 N/A* N/A* N/A*
PWA0103 Control M F Government Yes 3 Indonesia No Undergraduate
PWA011 Control F F Government Don’t know Not Applicable Iraq No Undergraduate
PWA012 Control F F Government No 0 Australia Yes Postgraduate
PWA013 Control F F Government Yes 2 Mauritius Yes High School
PWA014 Intervention F M Government Yes Don’t know UK Yes High School
PWA015 Intervention F M Government Yes 3 UK Yes Apprenticeship/
TAFE
PWA016 Intervention F F Government Yes 2 UK Yes Apprenticeship/
TAFE
PWA017 Intervention F F Government Yes 2 Australia Yes Apprenticeship/
TAFE
PWA018 Intervention F F Catholic Yes Don’t know Australia Yes Undergraduate
PWA019 Intervention F F Catholic Yes 3 Australia Yes Apprenticeship/
TAFE
PWA020 Intervention F F Catholic Yes 3 Australia Yes High School
PWA021 Intervention F M Catholic Yes 3 Australia Yes Postgraduate








































1 Data reported by parent.
2 Aboriginal or Torres Strait Islander.
3 Participants PWA009 and PWA010 parent the same child. *N/A = No answer.
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about vaccination, with some commenting that they discussed vac-
cination with their adolescent. Parents (primarily mothers) gener-
ally made the decision to vaccinate their adolescents alone, or
sometimes with a partner. They highlighted the importance of per-
sonal experience of HPV infection or of other cancers, and cancer
experiences of family or close friends, strongly influencing their
decision to offer consent for HPV vaccination for their adolescent:
I don’t want her to get HPV or cervical cancer and have scares like I
have had’ (PWA001, Control). Parents across study arms had diffi-
culty recalling or did not read HPV vaccination information pro-
vided from government sources or the study DST. One parent
(PWA008, C), who did not provide consent for her son to be vacci-
nated, reported that her older daughter had experienced an
adverse reaction to the vaccine: however, the parent was a strong
supporter of vaccination generally. Another parent (PWA012, C),
whose daughter had not been vaccinated, had changed schools
and had not yet sought vaccination elsewhere. Some parents sug-
gested that schools host education sessions with parents and ado-
lescents together about vaccination, and that parents could provide
vaccination consent at that time Table 3.
C. Parents’ knowledge about HPV and HPV vaccination is limited,
especially regarding males
Most parents knew that HPV is sexually transmitted, and
many understood that HPV can cause cervical cancer. Most par-
ents had limited or no knowledge about other HPV-related dis-4193eases or the benefits of HPV vaccination for males. Some
surmised that males should be vaccinated because they may
transmit the virus:
I am not quite sure of [. . .] what it causes in boys – if it causes can-
cer, but at the end of the day you know you want to stop not only
someone from getting it but from somebody who can pass it on.
(PWA018, Intervention)
Parents’ decision to vaccinate their adolescents, especially males,
was largely a result of inclusion of the HPV vaccine in the Program.
For example, one parent reported: ‘I know nothing about it. I don’t
know what it is for. I just know that he had it’ (PWA003, Control).While
parents did not appear to have knowledge about the relationship
between HPV vaccination and cervical screening, some parents sur-
mised that cervical screening would most likely still be recom-
mended regardless of HPV vaccination status. All parents wanted
their adolescents educated about HPV, HPV vaccination and vaccina-
tion more broadly, at school before adolescent vaccination com-
menced. Of note, unlike parents from control schools, some parents
of adolescents in intervention schools reported that their adolescents
were ‘clued up’ about HPV vaccination, and that their adolescent ini-
tiated discussion about vaccination with parents at home Table 4.4. Discussion and recommendations
We found that parents had positive attitudes towards the Pro-
gram in general and that the school delivery platform was the
Table 2
Snapshot of parents’ positive attitudes towards school-based vaccination (SBV).
Trust in clinicians, researchers, and
government
If it is coming from the government and
the Health Department [. . .] I don’t have
any issues with yes to that. That it is all
official. (PWA003, Control)
I know that it would have gone through
clinical trials and that yeah, I think it is a
good thing to have him vaccinated. So
that was an easy decision to make for me
really. (PWA015, Intervention)
Parents liked adolescents receiving
peer support on vaccination day
‘. . .[at school] she has got that support of
her friends rather than you know at that
age, getting dragged to the doctor with
your mum. . .’ (PWA017, Intervention)
I think it helps when they are older
getting it all done with their peers
because you try not to look so frightened
in front of all your peers. (PWA018,
Intervention)
Parents found the school-based
setting for HPV vaccination
administration convenient
I think the advantages are definitely that
it is done in school so you haven’t got to
make extra appointments[. . .]Having it
in school it is all in one place [. . .]you
have got a captive audience [. . .]And you
know that they have done it. (PWA016,
Intervention)
I think if it is left to parents—you know
most parents work, to take time off at the
end of the day it means the parents will
lose dollars, they will forget, they will put
it off. I am one of them [sic.] people that
could do that quite easily if it means
earning money for my family. So, I think
that if it can be done at schools um, yeah,
that you are probably going to get 90%
turnaround of actually getting them
done. Yeah, I think that is a good idea.
(PWA005, Control)
I just think a lot of parents wouldn’t do it
if they had to do it off their own bat. [. . .]
It is definitely better doing it at school.
Everyone is there and they all just go and
get it [. . .]. And I think if you did it having
to go to the doctor people who consented
some of them wouldn’t go; it is extra
effort isn’t it? (PWA003, Control).
Yeah, I mean the main thing for me is
that I think about those vaccinations is
the time it takes for someone to pull a kid
out of school to take them to
appointments it means they are missing
education and for me, I would rather him
have it there so he is not offsite doing
other things. Um, and I just think that
more of these services need to go into
schools rather than pull them out.
(PWA005, Control).
Parents want a record of adolescent
vaccinations
An email or a letter home to say that she
is up to date would have been a good
idea. Because, sometimes people are
asked for immunisation records and you
just lose track of what your child has had.
(PWA001, Control)
Vaccination consent forms A lot of kids I understand, like my
younger son, doesn’t bring all the stuff
home. But [my older son] is a very
organised, responsible boy [. . .]. So, it is
still the responsibility of the child to hand
that stuff over so that might be a bit of a
problem. (PWA005, Control)
Table 3
HPV vaccine inclusion in the SBV is central to parents’ vaccine decision-making and
acceptance.
HPV vaccine inclusion in SBIP central
to acceptance
I don’t know a huge amount about it.
[. . .] I just tick yes . . . and let them go
for it. (PWA003, Control)
Most adolescents trust parents to
make best decision. Some parents
discuss decision with their
adolescent.
It was my decision. I told her right from
an early stage that when she got to
Grade 8 that is what she would be
doing. (PWA002, C)
No, it was just you are going to get it
[the HPV vaccine]. (PWA003, Control)
Yeah, he was definitely for this [. . .]– I
made a decision about his having the
injections and I sort of talked to him
through about why that was. He was
okay with it, but I still think at his age
um, you need to give them a little bit
more information about why that is so.
(PWA005, Control)
I asked him, you know, what he
understood about it and why, you
know, the reasons why I thought it was
being given and he understood, and he
was quite happy to go forward with it.
(PWA015, Intervention)
Some parents made decision to
vaccinate based on personal
experience, or experience of
family and close friends, of HPV
infection or cancer more broadly.
I had already made that decision prior
to getting the information when I first
heard what it is about. I have had
friends who have the HPV and I know
how prevalent it can be and how easy it
can be to get. So, I had already made up
my mind that once she was at school
that she would get whatever was on
offer. (PWA018, Intervention)
I would have taken her because I don’t
want her to get HPV or cervical cancer
and have scares like I have had.
(PWA001, Control)
I think anything that can have any
opportunity to prevent anything I am
all for because I have lost you know my
mum and dad to cancer. So yeah, I will
take whatever I can get to help my kids
have a better opportunity with not
being predisposed to a lot of health
issues. (PWA005, Control)
Parents from intervention schools
observed adolescents appeared
educated about HPV vaccination,
and initiated discussion at home.
My daughter seems very clued up
about it, so she has also discussed it at
home [. . .] [she] has mentioned other
benefits of the vaccine. (PWA016,
Intervention)
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4194key driver shaping acceptance of and decision-making about HPV
vaccination for their adolescent. Parents’ trust in advice from
health experts who are informed by evidence-based research
underpins their acceptance of HPV vaccine safety [29]. The impor-
tance of the vaccine was signalled by inclusion in the government
subsidised Program (NIP), thereby acting as a behavioural cue
prompting parents to vaccinate their adolescent. Our study, under-
taken from 2013 after males were included in the Program, showed
that parents’ knowledge about HPV and HPV vaccination was pri-
marily focused on cervical cancer and prevention. Their knowledge
was limited regarding other HPV-related diseases and benefits of
the vaccine for males. However, we also discovered that the provi-
sion of gender-neutral HPV vaccination signals to parents the
Table 4
Parents’ knowledge about HPV and HPV vaccination is limited, especially regarding
males.
Many parents knew that HPV is
sexually transmitted
I think it is transmitted through sexual
contact. (PWA005, Control)
Most understood the link to cervical
cancer
I know that in women it can be a sort of
[be] a triggering thing that can lead to
cervical cancer. (PWA005, Control)
Limited/no knowledge about HPV
vaccination and boys.
I don’t know, I mean, can it -it can lead
to diseases in boys, that boys get?
(PWA001, Control)
Um, and I don’t really know how that
translates to something for the boys.
(PWA005, Control)
I think at the moment they are
developing one [vaccine] for boys too
aren’t they, a different vaccine.
(PWA002, Control)
I know nothing about it. I don’t know
what it is for. I just know that he had it.
(PWA003, Control)
I guess that the thing that stands out for
me is that I don’t really have much of an
idea of about what it is all – what the
issues are for boys. Is that about warts
for them, or something like that?
(PWA005, Control)
It just brought to my attention that I
don’t have as much information about
the prevalence of that for boys.
(PWA005, Control)
Parents wanted their adolescents
educated about HPV and HPV
vaccination at school
I can’t remember if she said they did
have a discussion or not. But if they
didn’t, I feel that would be a valuable
thing at the school— perhaps as a prior
thing to have that discussion with them.
(PWA002, Control)
We got the form so in that way you
could say it was successful but as I said
it comes back to whether the prior
information was given. (PWA002,
Control)
I don’t think there was any proper
education on it. (PWA002, Control).
It is a good thing to talk about. We talk
about that sort of thing quite a bit, so we
have no worries. (PWA003, Control)
Parents suggested different ways of
information about HPV
vaccination being shared with
them.
I mean you could try offering parents an
information evening where parents and
children come along and you do
something altogether in that respect.
(PWA002, Control)
C. Davies, T. Stoney, H. Hutton et al. Vaccine 39 (2021) 4190–4198importance of HPV vaccination for all adolescents. Given that trust
is a key element of vaccine confidence [30], monitoring parents’
trust and attitudes towards HPV vaccination may assist in identify-
ing vaccine safety concerns should they arise.
While there has been important work undertaken on
identifying the nuances between individual HPV vaccine
decision-making styles amongst parents, enabling key groups to
be identified and targeted in communication strategies
[9,10,31–33], our study has elucidated that HPV vaccine decision-
making for parents is heavily influenced by program inclusion
and delivery platforms. An ecological framework is very useful to
understand complex systems of influence that go beyond4195individual behaviours and attitudes to incorporate organisational
and public policy contexts. These factors are critical elements
shaping parent HPV vaccine decision-making. Effective, timely
and accurate communication about HPV vaccination remains a
challenge for HPV vaccination programs, regardless of program
platform [22,34–36]. While most parents in this study did not read
or could not recall the HPV vaccination information sent home, it
was of interest that parents with adolescents in intervention
schools observed that their adolescent appeared well informed,
positive, and initiated discussions about having the vaccine. While
studies, including ours, show that adolescents generally trust their
parents’ HPV decision-making and that adolescents become more
involved in vaccination decisions as they mature [37], we found
that ultimate HPV decision-making is generally the domain of par-
ents for adolescents aged 12–14 years.
Our study showed that cancer prevention resonates strongly with
parent decision-making, which relates to general attitudes to cancer
in society as frightening and a common experience. As cervical can-
cer becomes less common with increased HPV vaccination coverage
and cervical screening, experiences of cancer may remain an impor-
tant driver of HPV vaccine decision-making because of the common
experience of cancer generally. Even though this may suggest that
we should frame the HPV vaccine as a cancer-prevention vaccine,
it does not preclude explaining that the virus is sexually transmitted
[22,38,39]. Most parents in this study understood that HPV is sexu-
ally transmitted and because they lacked knowledge about the ben-
efits of vaccination for males—a finding consistent with other studies
[9,10,33]—some surmised that males should be vaccinated because
they may transmit the virus. At the time this study was undertaken,
males were new to the Program and messaging to females had dom-
inated. HPV vaccine coverage for males turning 15 years old in 2014
(the first year after their inclusion in the Program) was 62.4% and
continued to rise for females at 74.8% [3]. Given that some parents
unaware of the risk of HPV in males have been less likely to accept
HPV vaccination for their sons, and that requiring more information
about HPV vaccination for males has served as a barrier to parent
decision-making [33], it may be prudent to implement good commu-
nication strategies through existing mechanisms in schools and
through health providers.
Schools are ideally positioned to integrate positive public health
messages such as educating adolescents about HPV, HPV vaccina-
tion, screening, and vaccination more broadly and to implement
effective communication strategies about the benefits of HPV vac-
cination to parents [22]. All parents in this study supported in-
school education about HPV and HPV vaccination before adoles-
cents are vaccinated and adolescent involvement in their own
healthcare. In-school education about HPV vaccination can assist
in the development of adolescents’ knowledge and understanding,
thus improving their HPV vaccination health literacy [22]. Parents
should also be informed that younger adolescents achieve a better
immune response to vaccination, are more likely to be HPV naïve,
and that completion of HPV vaccination can be undertaken without
needing to restart the course regardless of the length of time since
the previous dose [36,40]. Parents may also benefit from instruc-
tion on how to access their adolescent’s vaccination records in a
consumer friendly way, which alongside other strategies [35,41–
43], may assist with HPV vaccine initiation and completion.
Australia has a long record of delivering vaccines through a
school-based platform, resulting in rapid decline in vaccine pre-
ventable diseases and uptake consistently higher in adolescents
than other strategies [17,44]. The transformation of the school-
setting into a temporary clinical space for vaccination has some
organisational challenges, such as consent form non-return,
catch-up doses resulting from student absenteeism, effective com-
munication to parents and adolescents, and managing student anx-
iety [4,22,34,35,43]. However, this public health intervention has
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inherent in healthcare settings with those in educational settings.
Parents were cognisant of the social norms inherent in the
school-setting, in which descriptive norms (behaviour of relevant
others by example) and injunctive norms (how important others
influence behaviour through informal reinforcement) are already
firmly established, and therefore impact the administration of vac-
cination and adolescent behaviour [45]. Subjective norms (the
extent to which people important to the adolescent want them
to be vaccinated), which correspond to injunctive norms have also
been correlated with intention to vaccinate and associated with
vaccination behaviour [45]. Parents recognised the benefits of ado-
lescent peer support on vaccination day, a mode of care enabled
through the school-setting without visiting a doctor (often associ-
ated with a specific health need or illness) suited to the majority of
adolescents at their developmental stage. Time-poor parents ben-
efit from the convenience of having their adolescent’s preventative
healthcare needs met in the very place where the young person is
generally mandated to receive their education. School-based pro-
grams also assist in addressing inequity of access to HPV vaccina-
tion for marginalised adolescents and there is continued focus on
identifying implementation strategies to further reduce these gaps
[17,35,46–49].5. Limitations
Parents who responded to the study invitation to take part in an
interview may have been more likely to be interested in vaccina-
tion and research. The length of time between parents receiving
the DST/standard information and the interview, which took place
either after HPV dose two or three meant that parents experienced
difficulty recalling reading materials. The majority of parents
reported not reading materials sent home with consent forms.
Due to limited resources, study promotional materials were not
translated into other languages. Further research with parents
from culturally and linguistically diverse communities would be
valuable to understand parental attitudes, knowledge and
decision-making about HPV vaccination for adolescents in the con-
text of school-based program delivery. Three male parents from
the control group were available to participate in interviews, mak-
ing it difficult to draw comparisons between male and female par-
ents’ attitudes, perceptions and experiences. Further research with
male parents of HPV vaccine eligible adolescents involved in the
SBV Program may be of value to better understand the role of
fathers in HPV vaccination decision-making for their adolescent.
Due to the small numbers of parents in the intervention group,
identifying differences and drawing conclusions about differences
between control and intervention groups is not possible. A larger
sample across both groups would be required.6. Conclusions
Parents’ positive attitudes towards the Program and inclusion of
the HPV vaccine in the national vaccine schedule (NIP) is central to
parents’ vaccine decision-making and acceptance. Decision-making
for most parents appears to be heavily influenced by SBV and a fully
funded Program, alongside trust in health experts and government.
Implementing an accessible and convenient HPV vaccination pro-
gram with good processes and social reinforcements contributes to
program resilience, which may help assuage a vaccine safety scare.
While it is important to attend to the smaller percentage of parents
who are HPV vaccine hesitant, it is critical that we understand paren-
tal experiences of school-based vaccination so that we can identify
successful strategies and understand barriers to implementation of
adolescent vaccine programs. More intensive communication strate-4196gies, including the use of already existing communication mecha-
nisms and parent engagement strategies in schools, are likely to
yield the most impact in improving parents’ HPV vaccine knowledge,
consent form completion regardless of decision, and to promote vac-
cine decision-making with adolescents. Informing parents about the
benefits of vaccination for adolescents may assist in addressing lim-
ited health literacy about HPV-related disease and may impact par-
ents’ understanding of the importance of HPV vaccination of males.
Monitoring parents’ attitudes towards HPV vaccination may assist
in identifying any vaccine concerns to mitigate any reduction in vac-
cination uptake, particularly as misinformation about HPV vaccine is
regularly promoted.
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